Skip to main content

1 Result(s)

within Longjiang She Remove this filter

and

  1. No Access

    Article

    Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

    The purpose of this study was to estimate the cost-effectiveness of atezolizumab plus chemotherapy in patients with metastatic non-squamous non-small cell lung cancer (NSCLC) from the United States (US) payers...

    Dong Ding, Huabin Hu, Mengting Liao, Yin Shi, Longjiang She… in Advances in Therapy (2020)